Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 39/gram
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name:Crizotinib
CAS NO:877399-52-5
MF:C21H22Cl2FN5O
MW:450.34
Apperance:White Powder
Melting point :192 °C
Boiling point :599.2±50.0 °C(Predicted)
Density :1.47±0.1 g/cm3(Predicted)
Storage conditions :Room Temp
Crizotinib is a small-molecule tyrosine kinase inhibitor (TKI) that targets anaplastic lymphoma kinase (ALK), ROS1, and another oncogene receptor tyrosine kinase, MET.Crizotinib capsules are indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) positive for anaplastic lymphoma kinase (ALK) as determined by an SFDA-approved test.
Capecitabine | Everolimus | Afatinib | Vandetanib | Gefitinib |
Temozolomid | Rapamycin | Axitinib | Sorafenib tosylate | Cediranib |
Cabozantinib | Selumetinib | Crizotinib | Sunitinib malate | Erlotinib |
Crizotinib | Lapatinib | Debrafenib | Cabazitaxel | Ponatinib |
1. Customs clearance